Clinical Trial Update: Dactinomycin in Treating Patients With Persistent or Recurrent Gestational Trophoblastic Neoplasia [Phase 2]

View source ↗

Summary

Phase 2 trial sponsored by the Gynecologic Oncology Group evaluating dactinomycin for persistent or recurrent gestational trophoblastic neoplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gestational Trophoblastic Neoplasia

Drugs mentioned

• Dactinomycin (dactinomycin)

Snippet

Sponsor: Gynecologic Oncology Group | Conditions: Gestational Trophoblastic Tumor | Phase 2 | Status: COMPLETED